HHS awards $2.27 billion grants to help Americans access HIV/AIDS care and meds

26 October 2019
hiv_aids_big

The US Department of Health and Human Services on Friday announced approximately $2.27 billion in Ryan White HIV/AIDS Program grants were awarded to cities, counties, states, and local community-based organizations in fiscal year (FY) 2019.

This funding, through the Health Resources and Services Administration (HRSA), supports a comprehensive system of HIV primary medical care, medication, and essential support services to more than half a million people with HIV in the USA.

“The Ryan White HIV/AIDS Program has played a major role in the in the improved outcomes we see for Americans with HIV,” said HHS Secretary Alex Azar, explaining: “Thanks to expanded access to treatment and medical advances, HIV/AIDS has gone from being a likely death sentence to a condition that allows a nearly normal lifespan if properly treated. Ryan White HIV/AIDS Program clients, despite often very challenging circumstances, have a viral suppression rate that far exceeds the national average.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical